This inventor holds 1 USPTO granted patent. Top assignee: King Abdulaziz University. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Innovations in Cancer Treatment by Mohammad Imran Khan
Introduction
Mohammad Imran Khan is a notable inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of cancer treatment through his innovative research and patent developments. His work focuses on therapeutic compounds that have the potential to improve treatment outcomes for breast and pancreatic cancer.
Latest Patents
One of his key patents is titled "Arylacetamides as AMP-activated protein kinase inhibitors and their use for treatment of breast cancer." This patent describes therapeutic compounds containing an arylacetamide core with a pending N-benzyl group. The invention also includes pharmaceutical compositions that incorporate these therapeutic compounds and outlines a method for inhibiting AMP-activated kinase (AMPK). The compounds are specifically designed for treating breast and pancreatic cancer.
Career Highlights
Mohammad Imran Khan is affiliated with King Abdulaziz University, where he conducts his research and development activities. His work has garnered attention for its potential impact on cancer therapies, showcasing his commitment to advancing medical science.
Collaborations
He collaborates with esteemed colleagues, including Abdelsattar Mansour Omar and Moustafa Elsayed El-Araby. These partnerships enhance the research efforts and contribute to the innovative environment at King Abdulaziz University.
Conclusion
Mohammad Imran Khan's contributions to cancer treatment through his patented innovations highlight the importance of research in developing effective therapies. His work continues to inspire advancements in the medical field.